Evaluation of antithrombotic use and COVID-19 outcomes in a nationwide atrial fibrillation cohort | Heart

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via BCS

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article metrics

PDF +
Supplementary
Material

Cardiac risk factors and prevention

Original research

Evaluation of antithrombotic use and COVID-19 outcomes in a nationwide atrial fibrillation cohort

Online download statistics by month:

Online download statistics by month: March 2022 to March 2024

	Abstract	Full	Pdf
Mar 2022	1284	1314	230
Apr 2022	800	811	119
May 2022	632	633	96
Jun 2022	604	599	109
Jul 2022	187	182	35
Aug 2022	155	147	49
Sep 2022	161	155	61
Oct 2022	136	126	217
Nov 2022	122	116	32
Dec 2022	138	118	33
Jan 2023	92	90	32
Feb 2023	177	164	31
Mar 2023	153	151	56
Apr 2023	92	88	28
May 2023	61	52	20
Jun 2023	84	74	19
Jul 2023	66	50	13
Aug 2023	55	46	16
Sep 2023	55	46	18
Oct 2023	157	160	7
Nov 2023	60	59	14
Dec 2023	70	68	27
Jan 2024	74	74	51
Feb 2024	61	56	28
Mar 2024	127	125	148
Total	5603	5504	1489